These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24500410)

  • 1. Impact of diabetes mellitus on the clinical response to cardiac resynchronization therapy in elderly people.
    Sardu C; Marfella R; Santulli G
    J Cardiovasc Transl Res; 2014 Apr; 7(3):362-8. PubMed ID: 24500410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes.
    Sardu C; Barbieri M; Santamaria M; Giordano V; Sacra C; Paolisso P; Spirito A; Marfella R; Paolisso G; Rizzo MR
    Cardiovasc Diabetol; 2017 Jun; 16(1):75. PubMed ID: 28599667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes.
    Sardu C; Barbieri M; Rizzo MR; Paolisso P; Paolisso G; Marfella R
    J Diabetes Res; 2016; 2016():7292564. PubMed ID: 26636106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological treatment changes of chronic heart failure during cardiac resynchronization therapy: A 1-year follow-up study.
    Rinkuniene D; Krivickiene A; Laukaitiene J; Jurkevicius R
    Int J Cardiol; 2017 Jul; 238():92-96. PubMed ID: 28363688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Long-Term Survival Benefits With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Versus Without Diabetes Mellitus (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy [MADIT-CRT]).
    Kutyifa V; Naqvi SY; Brown M; McNitt S; Goldenberg I; Klein H; Moss AJ
    Am J Cardiol; 2018 Jun; 121(12):1567-1574. PubMed ID: 29625702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac resynchronization therapy allows the optimization of medical treatment in heart failure patients.
    Kachboura S; Ben Halima A; Ibn Elhadj Z; Marrakchi S; Chrigui R; Kammoun I; Chine S; Lefi A
    Ann Cardiol Angeiol (Paris); 2014 Feb; 63(1):17-22. PubMed ID: 23932251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Drug Utilization and Outcome With Cardiac Resynchronization Therapy: A MADIT-CRT Substudy.
    Penn J; Goldenberg I; McNitt S; Polonsky B; Ruwald MH; Zareba W; Moss AJ; Alexis JD
    J Card Fail; 2015 Jul; 21(7):541-7. PubMed ID: 25800548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study.
    Berger R; Shankar A; Fruhwald F; Fahrleitner-Pammer A; Freemantle N; Tavazzi L; Cleland JG; Pacher R
    Eur Heart J; 2009 Sep; 30(17):2109-16. PubMed ID: 19493864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Diabetes Mellitus on Cardiac Resynchronization Therapy and to Prognosis in Heart Failure (from the Prospective Evaluation of Asian With Cardiac Resynchronization Therapy for Heart Failure Study).
    Tan ESJ; Lim J; Chan SP; Seow JT; Singh D; Yeo WT; Lim TW; Kojodjojo P; Seow SC
    Am J Cardiol; 2019 Sep; 124(6):899-906. PubMed ID: 31326077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of heart failure medication after cardiac resynchronization therapy and the impact on long-term survival.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Nielsen JC
    Eur Heart J Cardiovasc Pharmacother; 2015 Jul; 1(3):182-8. PubMed ID: 27533993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Optimization of Medical Treatment on Long-Term Survival of Patients With Heart Failure After Implantable Cardioverter Defibrillator and Cardiac Resynchronization Device Implantation (from the French National EGB Database).
    Massoullié G; Chouki C; Mulliez A; Rossignol P; Ploux S; Pereira B; Reuillard A; Jean F; Andronache M; Eschalier A; Motreff P; Clerfond G; Bordachar P; Authier N; Eschalier R
    Am J Cardiol; 2018 Mar; 121(6):725-730. PubMed ID: 29402420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to heart failure management medications following cardiac resynchronization therapy.
    Shah BR; DerSarkissian M; Tsintzos SI; Xiao Y; May D; Lu X; Kinrich D; Davis E; Lefebvre P; Duh MS; Dasta JF
    Curr Med Res Opin; 2020 Feb; 36(2):199-207. PubMed ID: 31535559
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac resynchronization therapy and bone marrow cell transplantation in patients with ischemic heart failure and electromechanical dyssynchrony: a randomized pilot study.
    Pokushalov E; Romanov A; Corbucci G; Prohorova D; Chernyavsky A; Larionov P; Terekhov I; Artyomenko S; Kliver E; Shirokova N; Karaskov A; Dib N
    J Cardiovasc Transl Res; 2011 Dec; 4(6):767-78. PubMed ID: 21547598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy.
    Schmidt S; Hürlimann D; Starck CT; Hindricks G; Lüscher TF; Ruschitzka F; Steffel J
    Eur Heart J; 2014 Apr; 35(16):1051-60. PubMed ID: 24371079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CArdiac resynchronization in combination with beta blocker treatment in advanced chronic heart failure (CARIBE-HF): the results of the CARIBE-HF study.
    Grosu A; Senni M; Iacovoni A; Gori M; Cantù F; Bisetti S; De Santo T; De Luca A; Gavazzi A
    Acta Cardiol; 2011 Oct; 66(5):573-80. PubMed ID: 22032050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronization therapy in patients with heart failure and moderately reduced ejection fraction: Could it trigger a super-response?
    Tawfik Ghanem M; Allam LE; Samir Ahmed R
    Indian Heart J; 2019; 71(3):229-234. PubMed ID: 31543195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and Association of Neurohumoral Blocker Up-titration After Cardiac Resynchronization Therapy.
    Martens P; Verbrugge FH; Nijst P; Bertrand PB; Dupont M; Tang WH; Mullens W
    J Card Fail; 2017 Aug; 23(8):597-605. PubMed ID: 28284756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Frailty Assessment for Elderly Patients Undergoing Cardiac Resynchronization Therapy.
    Kubala M; Guédon-Moreau L; Anselme F; Klug D; Bertaina G; Traullé S; Buiciuc O; Savouré A; Diouf M; Hermida JS
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1523-1533. PubMed ID: 29759834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of aetiology on long-term effects of resynchronization on cardiac structure and function in patients treated with β-blockers.
    Zacà V; Baiocchi C; Gaddi R; Gentilini R; Lunghetti S; Padeletti M; Pagliaro A; Furiozzi F; Mondillo S; Favilli R
    J Cardiovasc Med (Hagerstown); 2011 Apr; 12(4):227-33. PubMed ID: 21252694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.